Q4 2024 Earnings Call Transcript March 3, 2025 Operator: Greetings. Welcome to Surgery Partners, Inc. Fourth Quarter 2024 ...

Welcome to Surgery Partners, Inc. Fourth Quarter 2024 Earnings Call. (Operator Instructions). As a reminder, this conference is being recorded. It is now my pleasure to introduce Dave Doherty, CFO.

Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash. The ...

LP (“Bain Capital”) to acquire all of the outstanding shares of Surgery Partners not already owned by Bain Capital for a cash consideration of $25.75 per share (the “Bain Capital Proposal”).

Here’s how five of the biggest ASC companies strengthened their market presence over the past year.

The analysts suggest that the decrease in hiring could be a signal that Surgery Partners is preparing for a potential transaction with Bain Capital. This anticipation of a deal could be ...

In other recent news, Surgery Partners has seen a flurry of activity. The company received a proposal from Bain Capital to acquire all remaining shares at $25.75 each. This proposition is ...

Equity LP's, the private equity arm of Bain Capital LP, proposed acquire of the remaining 60.7% shares in surgical facilities provider Surgery Partners Inc. for $6.96 billion was the largest deal ...

Surgery Partners' market value is estimated at $4.3 billion ($33.69 per share), and the company expects to generate revenue of $3.05 billion in 2024. Bain Capital acquired Surgery Partners from HIG ...

Bain Capital proposes to take Surgery Partners private Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it does not already ...

Bain Capital proposes to take Surgery Partners private Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it does not already ...

Roche was joined in the financing by a long list of venture investors in the round, including the American Cancer Society’s BrightEdge Ventures, ARK Investments, Bain Capital Life Sciences ...